Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. - Wikidata - wikimedia - TriplyDB

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

http://www.wikidata.org/entity/Q46741857

about

In vitro and in vivo models for the study of oral delivery of nanoparticles Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery.Polymeric nanomedicine for cancer MR imaging and drug delivery Targeted gene silencing using RGD-labeled chitosan nanoparticles.Amphiphilic cholic-acid-modified dextran sulfate and its application for the controlled delivery of superoxide dismutase.Assessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.Silver nanoaggregates on chitosan functionalized graphene oxide for high-performance surface-enhanced Raman scattering.Integrin targeted delivery of chemotherapeutics Recent advances of chitosan nanoparticles as drug carriers Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides Quantum dot/glycol chitosan fluorescent nanoconjugates.Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum components pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-D-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles Application of the central composite design to optimize the preparation of novel micelles of harmine.Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in bresat cancer cells: an improved nanomedicine strategies.Review: doxorubicin delivery systems based on chitosan for cancer therapy.Integrin targeted drug and gene delivery.Overview of the main methods used to combine proteins with nanosystems: absorption, bioconjugation, and encapsulation.Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.Antiangiogenic anticancer strategy based on nanoparticulate systems.Polysaccharides as building blocks for nanotherapeutics.Functional enhancement of chitosan and nanoparticles in cell culture, tissue engineering, and pharmaceutical applications.Fluorescence bioimaging with conjugated polyelectrolytes.Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood.Carbohydrate-based amphiphilic nano delivery systems for cancer therapy.Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy.Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.Polysaccharide-based Nanoparticles for Gene Delivery.Glycosylated star-shaped conjugated oligomers for targeted two-photon fluorescence imaging.Bright far-red/near-infrared conjugated polymer nanoparticles for in vivo bioimaging.Conjugated polyelectrolyte-cisplatin complex nanoparticles for simultaneous in vivo imaging and drug tracking.

P2860

Q26829514-68FB2522-9615-4440-9075-3116A73A48A8 Q31127810-799D8B34-B55A-47C6-A26F-D18D4F6BA37C Q33603580-4FE067DB-59D3-4EEB-855A-E3E02BC081C3 Q33773418-BC9BA326-A5B3-4F8B-8E15-903E93DBEE87 Q34031859-732119E0-D280-4D58-8C54-C30806B007F3 Q34274061-16C4A11C-7252-4D21-9A46-52F77AE52BF5 Q34331895-231F11B2-1D1E-4C65-9CCD-F34D2D54B5AF Q34733812-F5A75011-2A9A-423C-A646-5297B9B7BD20 Q34780593-C0D7A046-B916-4B62-AED0-26BEBC0A145F Q34788484-B2384818-20C8-4F7B-9EAA-A42D7F03C663 Q34912725-E7920164-50A6-4CB5-BAFB-BC5607685FE4 Q34956317-1544AAF7-D609-42D1-9EE8-6E2B3B74A5F0 Q35246152-21824835-86EC-4103-A585-568108E736EB Q35435245-62B58132-8DF8-4BBD-A643-D74779AD3571 Q36298604-B7AA4A78-108F-460A-9556-2A9C1D744144 Q36367986-D6085CE4-E714-4118-92FC-17E47880F244 Q36372319-CFA90C71-989D-4F36-8552-31637815BEC0 Q36442194-FCC6E5FE-4A63-4E0B-8577-E00EAD02BCFB Q36839361-69B5BED5-A0DE-4579-AA9C-89143A9311CC Q37325256-32321758-F2F7-4C4C-9B4D-04B6134C27D6 Q37380142-74E88A76-DF16-4C99-930E-FE3C1A67EB1A Q37679945-EE457D49-2751-45B1-9D74-A27131660ACE Q37693763-101201BC-00E6-4AFF-B63B-D55F8F004732 Q37788222-5DF892F4-C5A8-4ABE-A855-9575ABB9CD8A Q37876400-C9FBA816-EC6D-4879-BE65-A2FE5AB94801 Q37956480-60868F02-31D7-45DD-9E73-6510B7A09F5F Q38039086-11A8C129-10CB-4F5A-BF7D-FA0DAA8A5C7B Q38042301-0703A32C-8E25-4425-AC0F-432442462F7A Q38126555-E04519D5-3F99-4E9C-9504-32118990E61A Q38204933-6E366BF0-0458-4377-B872-F7A65F2E4818 Q38260732-8A06D881-F943-4C92-8AF4-C9ACB8FFE667 Q38504324-C1B5DC4C-2D99-4BCD-ABEB-57F67245BE0F Q38560337-E66F11E4-059F-49B3-887F-E2EE74D1F941 Q38974572-33D221A8-D59F-4F86-8C11-C98659A9295F Q39101325-BA24EED2-0549-4DF6-8854-F8DB7D842B59 Q39137149-7B5294E3-C825-4960-A152-75FD07BB8108 Q39157625-7DA237FF-EBA8-48D5-AE46-C354090CC8C7 Q39323192-BEA4018A-3423-4695-9BB9-CB355E9988F5 Q39428600-3B3D5596-9695-4FD2-A64C-26462373656D Q39569676-2D74D0C1-E272-4FD9-9B40-74071B6F3572

P2860

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.

http://www.wikidata.org/entity/Q46741857

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@en

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@nl

type

label

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@en

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@nl

prefLabel

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@en

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@nl

P1433

Q46741857-E5772D47-73B5-46EA-994E-D60B29B06FCF

P1476

Q46741857-95F3C376-C2FE-4000-8D34-A91D98094846

P2093

Q46741857-0F772CF6-6B95-476D-ADB2-8FE826B72433

Q46741857-662FFCF9-2665-4B55-A103-AF39BCBBE82D

Q46741857-84DCDC67-DBF2-4B41-9D7D-9934D056E3C7

Q46741857-94AFC412-0A56-417E-9DC7-3595BFC32A5C

Q46741857-A717B5D4-82AB-4208-9CCD-6B43BD6B2051

Q46741857-C4BE1929-4FC9-489F-AB18-0F4BE01F9B16

Q46741857-E9181C8A-158D-4C4F-842E-4887DCD112A4

Q46741857-F2865387-92B6-45DE-93DD-F4CF5A7CB082

P304

Q46741857-C43512F5-3ADF-4140-BE94-2057462EAD9D

P31

Q46741857-2D1BA936-0A2C-4591-8B76-9BA4AC648F1B

P356

Q46741857-53446DA7-F53E-4ECF-9043-57C944912F2E

P433

Q46741857-EAE295A0-E37C-4DC1-A648-435AF55A46FE

P478

Q46741857-7DCAD956-92FC-4F16-94FE-65FBD547B0D3

P50

Q46741857-08090C86-5891-4DEB-8B5C-18C1D876EC61

Q46741857-429D67CA-B179-44E5-88B1-8FF91F573082

Q46741857-56BE5857-278C-434B-B08C-DE4A8CD1F013

Q46741857-75AACBE9-84E6-4B72-9A93-DFF2AB6A5193

Q46741857-916101CA-E29C-4C58-9835-3A076BF51E11

P577

Q46741857-5CBF7707-AECC-4329-A590-7175062CFAEE

P5875

Q46741857-B0098A79-644A-43CB-A7E8-798DA66C09A3

P698

Q46741857-5BCB5546-D4BD-41F4-BA6F-08DB348A64BD

P921

Q46741857-D3B73775-FEC7-4FC6-83A4-EB21E4CAC77D

Q46741857-EB12114B-002E-473E-ABF9-13D1F44E9D98

P356

J.BIOMATERIALS.2007.12.038

P1433

P1476

Self-assembled glycol chitosan ...... ptide drugs in cancer therapy.

@en

P2093

Dae Yoon Chi

http://www.w3.org/2001/XMLSchema#string

Eunah Kang

http://www.w3.org/2001/XMLSchema#string

Hae Yun Nam

http://www.w3.org/2001/XMLSchema#string

In-San Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Kyeongsoon Park

http://www.w3.org/2001/XMLSchema#string

Rang-Woon Park

http://www.w3.org/2001/XMLSchema#string

Yoo-Shin Kim

http://www.w3.org/2001/XMLSchema#string

P304

1920-1930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2007.12.038

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Kwangmeyung Kim

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5561842

http://www.w3.org/2001/XMLSchema#string

P698

18289669

http://www.w3.org/2001/XMLSchema#string

P921